For Information About Current Clinical Trials
More than 1,200 clinical trials, which have contributed to best practice standards for the care of patients.
Assessment of Clinical Effects of Cholesteryl Ester Transfer Protein Inhibition With Evacetrapib in Patients at a High-Risk for Vascular Outcomes
Description: The purpose of the ACCELERATE study is to evaluate the efficacy and safety of evacetrapib in participants with high-risk vascular disease (HRVD).
Drug: Evacetrapib 130mg daily; Drug: Placebo
Primary Investigator: Kereiakes
The Carl and Edyth Lindner Research Centerat The Christ Hospital
2123 Auburn Avenue, Suite 424, Cincinnati, OH 45219
Join Us on:
Web Design by TBH Creative